Found: 7
Select item for more details and to access through your institution.
Drug resistance profiles of mutations in the RET kinase domain.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Nintedanib and a bi-specific anti-VEGF/Ang2 nanobody selectively prevent brain metastases of lung adenocarcinoma cells.
- Published in:
- Clinical & Experimental Metastasis, 2020, v. 37, n. 6, p. 637, doi. 10.1007/s10585-020-10055-x
- By:
- Publication type:
- Article
Enhancing gastric cancer conventional chemotherapy effects by triple angiokinase inhibitor nintedanib in preclinical models.
- Published in:
- Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.1145999
- By:
- Publication type:
- Article
C-Jun is essential for normal mouse development and hepatogenesis.
- Published in:
- Nature, 1993, v. 365, n. 6442, p. 179, doi. 10.1038/365179a0
- By:
- Publication type:
- Article
Therapeutic impact of Nintedanib with paclitaxel and/or a PD-L1 antibody in preclinical models of orthotopic primary or metastatic triple negative breast cancer.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2019, v. 38, n. 1, p. N.PAG, doi. 10.1186/s13046-018-0999-5
- By:
- Publication type:
- Article
Tumour-infiltrating neutrophils counteract anti-VEGF therapy in metastatic colorectal cancer.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Aberrant TIMP‐1 production in tumor‐associated fibroblasts drives the selective benefits of nintedanib in lung adenocarcinoma.
- Published in:
- Cancer Science, 2024, v. 115, n. 5, p. 1505, doi. 10.1111/cas.16141
- By:
- Publication type:
- Article